These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36429722)

  • 21. Serum markers of gut permeability and endotoxemia in patients with osteoarthritis of the knee associated with metabolic syndrome.
    Shirinsky I; Kalinovskaya N; Filatova K; Shirinsky V
    Int J Rheum Dis; 2023 Nov; 26(11):2344-2346. PubMed ID: 37345895
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypovitaminosis D is Associated with Endothelial Dysfunction in Patients with Metabolic Syndrome.
    Oruc CU; Akpinar YE; Amikishiyev S; Uzum AK; Salmaslioglu A; Gurdol F; Omer B
    Curr Vasc Pharmacol; 2017; 15(2):152-157. PubMed ID: 27697067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The relationship between metabolic syndrome and target organ damage in Ghanaian with stage-2 hypertension.
    Bello-Rodriguez BM; Sanchez-Cruz G; Delgado-Bustillo F; Asiama G
    Ghana Med J; 2013 Dec; 47(4):189-96. PubMed ID: 24669025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of metabolic syndrome severity to assess treatment with vitamin E and pioglitazone for non-alcoholic steatohepatitis.
    Gurka MJ; Mack JA; Chi X; DeBoer MD
    J Gastroenterol Hepatol; 2021 Jan; 36(1):249-256. PubMed ID: 32506513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urine organic acids may be useful biomarkers for metabolic syndrome and its components in Korean adults.
    Haam JH; Lee YK; Suh E; Choi SW; Chun H; Kim YS
    Clin Chem Lab Med; 2021 Oct; 59(11):1824-1831. PubMed ID: 34331849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative performance of three metabolic syndrome definitions in the prediction of acute coronary syndrome.
    Koutsovasilis A; Protopsaltis J; Triposkiadis F; Kokkoris S; Milionis HJ; Zairis MN; Skoularigis J; Koukoulis G; Korantzopoulos P; Melidonis A; Foussas SG
    Intern Med; 2009; 48(4):179-87. PubMed ID: 19218766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparing the diagnostic ability of inflammatory markers in metabolic syndrome.
    Meng G; Zhu Q; Shao J; Zhang Q; Liu L; Wu H; Xia Y; Bao X; Gu Y; Wang H; Shi H; Sun S; Wang X; Zhou M; Jia Q; Wang G; Song K; Wu Y; Niu K
    Clin Chim Acta; 2017 Dec; 475():1-6. PubMed ID: 28974361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between ghrelin levels and markers of arterial stiffness and inflammatory markers in Saudi subjects with metabolic syndrome.
    Ali TM; Mehanna OM; El Askary A
    Diabetes Metab Syndr; 2017 Dec; 11 Suppl 2():S721-S725. PubMed ID: 28539201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Small dense low-density lipoprotein cholesterol is a useful marker of metabolic syndrome in patients with coronary artery disease.
    Nozue T; Michishita I; Ishibashi Y; Ito S; Iwaki T; Mizuguchi I; Miura M; Ito Y; Hirano T
    J Atheroscler Thromb; 2007 Aug; 14(4):202-7. PubMed ID: 17704616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aminotransferase levels as a prospective predictor for the development of metabolic syndrome in patients with schizophrenia.
    Kim EY; Kim SH; Lee NY; Yoon JS; Kim CE; Kim YS; Ahn YM
    Psychopharmacology (Berl); 2014 Dec; 231(23):4479-87. PubMed ID: 24819732
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proportional correlates of adipolin and cathepsin S in metabolic syndrome patients with and without prediabetes.
    Kasabri V; Al-Ghareeb MI; Saleh MI; Suyagh M; Halaseh L; Al-Sarraf I; AlAlawi S
    Diabetes Metab Syndr; 2019; 13(4):2403-2408. PubMed ID: 31405651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of epicardial fat volume and nonalcoholic fatty liver disease with metabolic syndrome: From the CAESAR study.
    Kim BJ; Kim HS; Kang JG; Kim BS; Kang JH
    J Clin Lipidol; 2016; 10(6):1423-1430.e1. PubMed ID: 27919360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of OSA on biological markers in morbid obesity and metabolic syndrome.
    Salord N; Gasa M; Mayos M; Fortuna-Gutierrez AM; Montserrat JM; Sánchez-de-la-Torre M; Barceló A; Barbé F; Vilarrasa N; Monasterio C
    J Clin Sleep Med; 2014 Mar; 10(3):263-70. PubMed ID: 24634623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted High Performance Liquid Chromatography Tandem Mass Spectrometry-based Metabolomics differentiates metabolic syndrome from obesity.
    Zhong F; Xu M; Bruno RS; Ballard KD; Zhu J
    Exp Biol Med (Maywood); 2017 Apr; 242(7):773-780. PubMed ID: 28299975
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery of metabolite profiles of metabolic syndrome using untargeted and targeted LC-MS based lipidomics approach.
    Gong LL; Yang S; Zhang W; Han FF; Lv YL; Xuan LL; Liu H; Liu LH
    J Pharm Biomed Anal; 2020 Jan; 177():112848. PubMed ID: 31479998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leptin/Adiponectin ratio as a potential biomarker for metabolic syndrome in patients with schizophrenia.
    Chen VC; Chen CH; Chiu YH; Lin TY; Li FC; Lu ML
    Psychoneuroendocrinology; 2018 Jun; 92():34-40. PubMed ID: 29625373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic Syndrome: Updates on Pathophysiology and Management in 2021.
    Fahed G; Aoun L; Bou Zerdan M; Allam S; Bou Zerdan M; Bouferraa Y; Assi HI
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of crocin on the symptoms of depression in subjects with metabolic syndrome.
    Jam IN; Sahebkar AH; Eslami S; Mokhber N; Nosrati M; Khademi M; Foroutan-Tanha M; Ghayour-Mobarhan M; Hadizadeh F; Ferns G; Abbasi M
    Adv Clin Exp Med; 2017 Sep; 26(6):925-930. PubMed ID: 29068592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying the metabolic syndrome in obese children and adolescents: do age and definition matter?
    van Vliet M; von Rosenstiel IA; Schindhelm RK; Brandjes DP; Beijnen JH; Diamant M
    Curr Clin Pharmacol; 2009 Sep; 4(3):233-8. PubMed ID: 19500071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical availability of non alcoholic fatty liver disease as an early predictor of the metabolic syndrome in Korean men: 5-year's prospective cohort study.
    Ryoo JH; Choi JM; Moon SY; Suh YJ; Shin JY; Shin HC; Park SK
    Atherosclerosis; 2013 Apr; 227(2):398-403. PubMed ID: 23390894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.